Direct chiral separation of troglitazone stereoisomers using reversed-phase high-performance liquid chromatography

A simple HPLC method for the direct chiral separation of troglitazone stereoisomers was developed. The separation was performed on a reversed-phase cellulose-derivertized chiral column (Chiralcel OJ-R) using a mobile phase consisting of methanol–acetic acid (1000:1, v/v) at a flow rate of 0.5 ml/min...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical and biomedical analysis 2002-10, Vol.30 (3), p.823-836
Hauptverfasser: Suzuki, Nobuyuki, Takemura, Akira, Miyamoto, Akifumi, Yoshioka, Takao, Tsutsumi, Shinya, Kawasaki, Takao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 836
container_issue 3
container_start_page 823
container_title Journal of pharmaceutical and biomedical analysis
container_volume 30
creator Suzuki, Nobuyuki
Takemura, Akira
Miyamoto, Akifumi
Yoshioka, Takao
Tsutsumi, Shinya
Kawasaki, Takao
description A simple HPLC method for the direct chiral separation of troglitazone stereoisomers was developed. The separation was performed on a reversed-phase cellulose-derivertized chiral column (Chiralcel OJ-R) using a mobile phase consisting of methanol–acetic acid (1000:1, v/v) at a flow rate of 0.5 ml/min. The peak areas of stereoisomers separated from 0.13 to 0.75 mg/ml of troglitazone had good linearity, with correlation coefficients >0.999 in the reversed-phase mode. The repeatability of the ratios of stereoisomers isolated from 0.5 mg/ml of troglitazone had a relative standard deviation of 0.1–0.2%. The relative sensitivities of the four isomers at UV 285 nm were similar, as each response factor was within the range of 0.99–1.01. Troglitazone racemized at the chiral center of the thiazolidine ring in methanol solution, but was found to be stable for 24 h in methanol–acetic acid (1000:1, v/v). This method was applied to the stereoisomeric analysis of troglitazone in pharmaceutical formulations and used to evaluate the constancy of the stereoisomer ratio in the manufacturing process and stability testing.
doi_str_mv 10.1016/S0731-7085(02)00391-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72156359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708502003916</els_id><sourcerecordid>72156359</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-f67b41f1d8e0fc12bcfb6dd2c247da881a9f467cd447a1917e2a54af48e4e5eb3</originalsourceid><addsrcrecordid>eNqFkc1u1TAQRi0EoreFRwBlA4JFwHYcO1lVqJRSqRILQGJnOfb4xiiJ03FSqX16fH9El12NrDnzeXxMyBtGPzHK5OefVFWsVLSpP1D-kdKqZaV8RjasUVXJpfjznGz-IyfkNKW_lNKateIlOWG8kio3NgS_BgS7FLYPaIYiwWzQLCFORfTFgnE7hMU8xAmKtABCDCmOgKlYU5i2BcJdPoAr594kKPqw7csZ0EcczWShGMLtGlwOxziaJW7RzP39K_LCmyHB62M9I7-_Xf66-F7e_Li6vvhyU9r8lqX0UnWCeeYaoN4y3lnfSee45UI50zTMtF5IZZ0QyrCWKeCmFsaLBgTU0FVn5P0hd8Z4u0Ja9BiShWEwE8Q1acVZLau6zWB9AC3GlBC8njGMBu81o3onW-9l651JTbney9Yyz709XrB2I7jHqaPdDLw7AiZZM3jMUkJ65Kq2qWq2484PHGQddwFQJxsgC3T7z9EuhidW-Qf095-0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72156359</pqid></control><display><type>article</type><title>Direct chiral separation of troglitazone stereoisomers using reversed-phase high-performance liquid chromatography</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Suzuki, Nobuyuki ; Takemura, Akira ; Miyamoto, Akifumi ; Yoshioka, Takao ; Tsutsumi, Shinya ; Kawasaki, Takao</creator><creatorcontrib>Suzuki, Nobuyuki ; Takemura, Akira ; Miyamoto, Akifumi ; Yoshioka, Takao ; Tsutsumi, Shinya ; Kawasaki, Takao</creatorcontrib><description>A simple HPLC method for the direct chiral separation of troglitazone stereoisomers was developed. The separation was performed on a reversed-phase cellulose-derivertized chiral column (Chiralcel OJ-R) using a mobile phase consisting of methanol–acetic acid (1000:1, v/v) at a flow rate of 0.5 ml/min. The peak areas of stereoisomers separated from 0.13 to 0.75 mg/ml of troglitazone had good linearity, with correlation coefficients &gt;0.999 in the reversed-phase mode. The repeatability of the ratios of stereoisomers isolated from 0.5 mg/ml of troglitazone had a relative standard deviation of 0.1–0.2%. The relative sensitivities of the four isomers at UV 285 nm were similar, as each response factor was within the range of 0.99–1.01. Troglitazone racemized at the chiral center of the thiazolidine ring in methanol solution, but was found to be stable for 24 h in methanol–acetic acid (1000:1, v/v). This method was applied to the stereoisomeric analysis of troglitazone in pharmaceutical formulations and used to evaluate the constancy of the stereoisomer ratio in the manufacturing process and stability testing.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/S0731-7085(02)00391-6</identifier><identifier>PMID: 12367708</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Anti-diabetic drug ; Biological and medical sciences ; Chemistry, Pharmaceutical ; Chiral column ; Chiral separation ; Chromans - analysis ; Chromans - chemistry ; Chromatography, High Pressure Liquid - methods ; General pharmacology ; Medical sciences ; Pharmacology. Drug treatments ; Reproducibility of Results ; Reversed-phase LC ; Stereoisomerism ; Thiazoles - analysis ; Thiazoles - chemistry ; Thiazolidinediones ; Troglitazone</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2002-10, Vol.30 (3), p.823-836</ispartof><rights>2002 Elsevier Science B.V.</rights><rights>2003 INIST-CNRS</rights><rights>Copyright 2002 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-f67b41f1d8e0fc12bcfb6dd2c247da881a9f467cd447a1917e2a54af48e4e5eb3</citedby><cites>FETCH-LOGICAL-c391t-f67b41f1d8e0fc12bcfb6dd2c247da881a9f467cd447a1917e2a54af48e4e5eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0731708502003916$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13983518$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12367708$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suzuki, Nobuyuki</creatorcontrib><creatorcontrib>Takemura, Akira</creatorcontrib><creatorcontrib>Miyamoto, Akifumi</creatorcontrib><creatorcontrib>Yoshioka, Takao</creatorcontrib><creatorcontrib>Tsutsumi, Shinya</creatorcontrib><creatorcontrib>Kawasaki, Takao</creatorcontrib><title>Direct chiral separation of troglitazone stereoisomers using reversed-phase high-performance liquid chromatography</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>A simple HPLC method for the direct chiral separation of troglitazone stereoisomers was developed. The separation was performed on a reversed-phase cellulose-derivertized chiral column (Chiralcel OJ-R) using a mobile phase consisting of methanol–acetic acid (1000:1, v/v) at a flow rate of 0.5 ml/min. The peak areas of stereoisomers separated from 0.13 to 0.75 mg/ml of troglitazone had good linearity, with correlation coefficients &gt;0.999 in the reversed-phase mode. The repeatability of the ratios of stereoisomers isolated from 0.5 mg/ml of troglitazone had a relative standard deviation of 0.1–0.2%. The relative sensitivities of the four isomers at UV 285 nm were similar, as each response factor was within the range of 0.99–1.01. Troglitazone racemized at the chiral center of the thiazolidine ring in methanol solution, but was found to be stable for 24 h in methanol–acetic acid (1000:1, v/v). This method was applied to the stereoisomeric analysis of troglitazone in pharmaceutical formulations and used to evaluate the constancy of the stereoisomer ratio in the manufacturing process and stability testing.</description><subject>Analysis</subject><subject>Anti-diabetic drug</subject><subject>Biological and medical sciences</subject><subject>Chemistry, Pharmaceutical</subject><subject>Chiral column</subject><subject>Chiral separation</subject><subject>Chromans - analysis</subject><subject>Chromans - chemistry</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Reproducibility of Results</subject><subject>Reversed-phase LC</subject><subject>Stereoisomerism</subject><subject>Thiazoles - analysis</subject><subject>Thiazoles - chemistry</subject><subject>Thiazolidinediones</subject><subject>Troglitazone</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1TAQRi0EoreFRwBlA4JFwHYcO1lVqJRSqRILQGJnOfb4xiiJ03FSqX16fH9El12NrDnzeXxMyBtGPzHK5OefVFWsVLSpP1D-kdKqZaV8RjasUVXJpfjznGz-IyfkNKW_lNKateIlOWG8kio3NgS_BgS7FLYPaIYiwWzQLCFORfTFgnE7hMU8xAmKtABCDCmOgKlYU5i2BcJdPoAr594kKPqw7csZ0EcczWShGMLtGlwOxziaJW7RzP39K_LCmyHB62M9I7-_Xf66-F7e_Li6vvhyU9r8lqX0UnWCeeYaoN4y3lnfSee45UI50zTMtF5IZZ0QyrCWKeCmFsaLBgTU0FVn5P0hd8Z4u0Ja9BiShWEwE8Q1acVZLau6zWB9AC3GlBC8njGMBu81o3onW-9l651JTbney9Yyz709XrB2I7jHqaPdDLw7AiZZM3jMUkJ65Kq2qWq2484PHGQddwFQJxsgC3T7z9EuhidW-Qf095-0</recordid><startdate>20021015</startdate><enddate>20021015</enddate><creator>Suzuki, Nobuyuki</creator><creator>Takemura, Akira</creator><creator>Miyamoto, Akifumi</creator><creator>Yoshioka, Takao</creator><creator>Tsutsumi, Shinya</creator><creator>Kawasaki, Takao</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20021015</creationdate><title>Direct chiral separation of troglitazone stereoisomers using reversed-phase high-performance liquid chromatography</title><author>Suzuki, Nobuyuki ; Takemura, Akira ; Miyamoto, Akifumi ; Yoshioka, Takao ; Tsutsumi, Shinya ; Kawasaki, Takao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-f67b41f1d8e0fc12bcfb6dd2c247da881a9f467cd447a1917e2a54af48e4e5eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Analysis</topic><topic>Anti-diabetic drug</topic><topic>Biological and medical sciences</topic><topic>Chemistry, Pharmaceutical</topic><topic>Chiral column</topic><topic>Chiral separation</topic><topic>Chromans - analysis</topic><topic>Chromans - chemistry</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Reproducibility of Results</topic><topic>Reversed-phase LC</topic><topic>Stereoisomerism</topic><topic>Thiazoles - analysis</topic><topic>Thiazoles - chemistry</topic><topic>Thiazolidinediones</topic><topic>Troglitazone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suzuki, Nobuyuki</creatorcontrib><creatorcontrib>Takemura, Akira</creatorcontrib><creatorcontrib>Miyamoto, Akifumi</creatorcontrib><creatorcontrib>Yoshioka, Takao</creatorcontrib><creatorcontrib>Tsutsumi, Shinya</creatorcontrib><creatorcontrib>Kawasaki, Takao</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suzuki, Nobuyuki</au><au>Takemura, Akira</au><au>Miyamoto, Akifumi</au><au>Yoshioka, Takao</au><au>Tsutsumi, Shinya</au><au>Kawasaki, Takao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct chiral separation of troglitazone stereoisomers using reversed-phase high-performance liquid chromatography</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2002-10-15</date><risdate>2002</risdate><volume>30</volume><issue>3</issue><spage>823</spage><epage>836</epage><pages>823-836</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>A simple HPLC method for the direct chiral separation of troglitazone stereoisomers was developed. The separation was performed on a reversed-phase cellulose-derivertized chiral column (Chiralcel OJ-R) using a mobile phase consisting of methanol–acetic acid (1000:1, v/v) at a flow rate of 0.5 ml/min. The peak areas of stereoisomers separated from 0.13 to 0.75 mg/ml of troglitazone had good linearity, with correlation coefficients &gt;0.999 in the reversed-phase mode. The repeatability of the ratios of stereoisomers isolated from 0.5 mg/ml of troglitazone had a relative standard deviation of 0.1–0.2%. The relative sensitivities of the four isomers at UV 285 nm were similar, as each response factor was within the range of 0.99–1.01. Troglitazone racemized at the chiral center of the thiazolidine ring in methanol solution, but was found to be stable for 24 h in methanol–acetic acid (1000:1, v/v). This method was applied to the stereoisomeric analysis of troglitazone in pharmaceutical formulations and used to evaluate the constancy of the stereoisomer ratio in the manufacturing process and stability testing.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>12367708</pmid><doi>10.1016/S0731-7085(02)00391-6</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 2002-10, Vol.30 (3), p.823-836
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_72156359
source MEDLINE; Elsevier ScienceDirect Journals
subjects Analysis
Anti-diabetic drug
Biological and medical sciences
Chemistry, Pharmaceutical
Chiral column
Chiral separation
Chromans - analysis
Chromans - chemistry
Chromatography, High Pressure Liquid - methods
General pharmacology
Medical sciences
Pharmacology. Drug treatments
Reproducibility of Results
Reversed-phase LC
Stereoisomerism
Thiazoles - analysis
Thiazoles - chemistry
Thiazolidinediones
Troglitazone
title Direct chiral separation of troglitazone stereoisomers using reversed-phase high-performance liquid chromatography
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T16%3A17%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20chiral%20separation%20of%20troglitazone%20stereoisomers%20using%20reversed-phase%20high-performance%20liquid%20chromatography&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Suzuki,%20Nobuyuki&rft.date=2002-10-15&rft.volume=30&rft.issue=3&rft.spage=823&rft.epage=836&rft.pages=823-836&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/S0731-7085(02)00391-6&rft_dat=%3Cproquest_cross%3E72156359%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72156359&rft_id=info:pmid/12367708&rft_els_id=S0731708502003916&rfr_iscdi=true